DO
David Owens
Chief Medical OfficerDirector

David Owens insider trades: Nexalin Technology (NXL) stock purchases

Chief Medical Officer, Nexalin Technology Last trade Feb 4, 2025 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 4, 2025NXL↑ Buy$3K
Feb 4, 2025NXL↑ Buy$3K
Jan 28, 2025NXL↑ Buy$4K
Jan 23, 2025NXL↑ Buy$8K
Oct 28, 2024NXL↑ Buy$1K
Aug 13, 2024NXL↑ Buy$950
Jun 28, 2024NXL↑ Buy$2K
Jun 18, 2024NXL↑ Buy$1K
Jun 10, 2024NXL↑ Buy$2K
Sep 16, 2022NXL↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David Owens's insider trades

David Owens is Chief Medical Officer at Nexalin Technology (NXL). Since Sep 16, 2022, David has reported 10 open-market purchases worth $35K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NXL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.